TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study.

Thierry André et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.